In-Depth Review: Sacheerome Limited SME IPO
Sacheerome Limited has become a key focus for investors tracking SME IPOs this June. This comprehensive review serves as your ultimate guide, breaking down the Grey Market Premium (GMP), subscription demand, potential listing gains, financials, and more.
What is GMP and Why Does It Matter?
Before we dive into the numbers, it's essential to understand the Grey Market Premium (GMP). GMP is the price at which IPO shares are traded unofficially before they are listed on the stock exchange. It's a key indicator of market sentiment and demand.
A positive GMP suggests that investors are willing to pay a premium over the issue price, signaling a potentially strong listing. However, it's crucial to remember that GMP is an informal metric and not a guarantee of the listing price.
Sacheerome IPO: Key Metrics at a Glance
A GMP of ₹30 over the ₹102 upper price band implies that the grey market anticipates a listing gain of approximately 29.4%. This high premium, coupled with strong subscription numbers, points towards significant investor interest.
The massive oversubscription is a clear signal of bullish sentiment. The robust participation from QIBs and HNIs shows institutional confidence, while the strong retail numbers highlight widespread investor excitement.
Business Snapshot & Financials
Company Overview
- Established: 1992
- Business: Manufacturer of fragrances (95% of revenue) and flavors (5% of revenue).
- Clients: B2B supplier to leading FMCG companies across personal care, home care, and food & beverage sectors.
Key Financial Data (₹ in Crore)
| Metric | FY23 | FY24 | H1 FY25 |
|---|---|---|---|
| Revenue | 70.49 | 85.09 | 50.80 |
| PAT (Profit After Tax) | 6.00 | 10.67 | 7.04 |
| EBITDA (%) | 14.6% | 19.0% | 20.3% |
| Net Worth | 35.30 | 46.00 | 62.00 |
| Total Debt | 0.00 | 1.43 | 3.47 |
Note: The company is operating its Okhla unit at 97% capacity utilization. This near-full capacity strongly justifies the planned Capex of ₹61.62 crore for a new manufacturing facility in Uttar Pradesh, funded by the IPO proceeds.
Strengths vs. Risks Analysis
Strengths & Opportunities
- High Capacity Utilization (97%): Indicates strong, existing demand for its products, validating the need for expansion.
- Blue-Chip B2B Clients: A strong order book is supported by relationships with top-tier FMCG companies, where the top 5 contribute ~50% of revenue.
- Impressive Profit Growth: Net profit surged by 78% YoY in FY24, showcasing operational efficiency and profitability.
- Industry Tailwinds: The Fragrance & Flavor (F&F) market is projected to grow at a CAGR of 8-10% in India, providing a favorable market environment.
Risks & Challenges
- Client Concentration: Heavy reliance on its top 5 clients (~50% of revenue) poses a risk if any of these relationships weaken.
- Geographic Concentration: Around 51% of sales originate from just two states (Maharashtra and Uttar Pradesh), making it vulnerable to regional issues.
- Raw Material Volatility: Prices of essential oils and aroma chemicals can be volatile, potentially impacting profit margins.
- Regulatory Hurdles: The business must adhere to strict standards from bodies like FSSAI and IFRA, and any non-compliance could be detrimental.
Interactive Listing Gain Calculator
Estimate Your Potential Listing Gains
Use the slider below to see how different GMP levels could affect the listing price and your potential profit. The IPO price is fixed at ₹102.
Case Study: Sacheerome vs. SH Kelkar
To provide context, let's look at a peer, SH Kelkar, which had its IPO in 2021. It debuted at a 20% pop over its issue price with a GMP of ₹18 on a ₹90 band. Today, SH Kelkar is trading approximately 40% higher than its issue price. This precedent suggests that Sacheerome, with a stronger GMP and subscription demand, could see comparable or even superior performance post-listing.
Interactive Poll: What's Your Move?
Are you applying after reading this review?
Test Your Knowledge!
What does a 20x subscription for an IPO indicate?
Final Thoughts & How to Check Allotment
This review should give you a clearer perspective on the Sacheerome IPO. To summarize the key takeaways:
- GMP is a sentiment indicator, not a guarantee.
- Subscription figures reflect real demand, which is currently very high.
- Strong fundamentals like high capacity utilization and industry growth support the IPO's objectives.
- Be mindful of concentration and raw material-related risks.
How to Check Your Allotment Status
Once the allotment is finalized, you can check your status on the registrar's website by following these steps:
- Visit the registrar's portal and select "Sacheerome Limited IPO".
- Choose to search by Application Number, PAN, or DP/Client ID.
- Enter your details and the captcha to view your allotment status.
Disclaimer: This content is for educational and informational purposes only and does not constitute financial advice or a buy/sell recommendation. Investing in the stock market, especially in SME IPOs, involves high risk. Please conduct your own due diligence or consult with a SEBI-registered financial advisor before making any investment decisions.
Pingback: Kalpataru IPO GMP, Price, Allotment & Listing Date